health

Are you being forced to list in 2020? Blame Alibaba.

Alibaba’s successful HK listing, combined with mounting pressure from PE investors, is forcing Chinese companies to consider listing in 2020 despite the woeful stock market performance of many who floated in 2019.

January 06, 2020

Short of breath? Chinese PE firms place bets on chronic respiratory disease

As global investment into healthcare dips, some pre-IPO investors hold high hopes one Chinese pharma company can take on AstraZeneca and win big in the China respiratory drug market.

January 05, 2020

Roundup: Chinese IPOs continue to drive Asian stock markets

Alibaba came back to Asia in November and dominated the equity landscape. But people are now starting to ask what markets next year are going to look like.

December 08, 2019

What does Chinese biotech want from professional investors?

Biotech investment is the new gold rush in China. But firms still struggle to find steady investment from private equity players and industry heavyweights.

November 25, 2019

Why Tencent wants a share in medical service platform

Tencent invested the third time into a medical service platform - a hot sector for investors right now.

November 20, 2019

SinoMab's $223m IPO extends HK biotech craze

SinoMab pushes forward with what could be the fourth-largest biotech listing in Hong Kong this year as investors' appetite for the sector picks up.

October 31, 2019

Chinese biotech's $53m IPO joins flurry of HK market activity

Even if Hong Kong's social landscape remains fractured, biotech firms continue to be lured to the HKEX, with Ascentage Pharma the latest to float.

October 23, 2019

KKR buys into Philippine hospitals operator amid Asian healthcare boom

Public investors miss out, at least for the time being, as Metro Pacific Investments shelves its planned $1.6 billion IPO of the fast-growing Metro Pacific Hospitals.

October 15, 2019

Chinese biomedical CRO seals $77m fundraising for R&D push

Animal gene modifier Beijing Biocytogen managed to draw on both government and private capital for its Series D funding round.

August 08, 2019

L Catterton hires Chinta Bhagat from Khazanah

LVMH’s affiliated private equity fund has strengthened its healthcare capability with Bhagat as co-managing partner.

August 06, 2019